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EDITORIAL
Obstructive  sleep  apnoea  syndrome  is  an
under-recognized cause  of  uncontrolled  asthma  acrossf
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differs  from  asthma  alone.  This  syndrome  is  usually  notthe life  cycle
Obstructive  sleep  apnoea  syndrome  (OSA)  is  a  clinical
syndrome  marked  by  recurring  episodes  of  upper  airway
obstruction  that  lead  to  markedly  reduced  (hypopnoea)  or
absent  (apnoea)  airﬂow  at  the  nose/mouth.  These  episodes
of  impaired  ventilation  are  usually  accompanied  by  loud
snoring  and  hypoxemia,  and  are  typically  terminated  by
brief  arousals.1 However,  despite  having  signiﬁcant  breath-
ing  problems  during  sleep,  most  patients  have  no  readily
detectable  respiratory  abnormality  while  awake.  OSA  is  a
very  common  yet  underdiagnosed  disorder  often  occurring
in  a  context  of  multimorbidity.2
The  pathophysiological  mechanisms  involved  in  OSA  are
complex  and  not  fully  understood.  Critical  upper  airway  nar-
rowing/collapse  usually  occurs  in  the  oropharynx,  between
the  nasal  choanae  and  epiglottis,  an  area  lacking  rigid
structural  support.  Patency  of  this  vulnerable  segment  is
dependent  on  the  action  of  pharyngeal  dilator  and  abductor
muscles  that  are  normally  activated  in  a  rhythmic  fashion
during  each  inspiration.  Collapse  of  the  upper  airway  occurs
if  the  negative  upper  airway  pressure  generated  by  inspira-
tory  pump  muscles  exceeds  the  dilating  force  of  these  upper
airway  muscles.3
A  variety  of  factors  contribute  to  upper  airway  narrowing
in  patients  with  OSA.  Obesity  contributes  to  OSA  patho-
genesis  in  multiple  ways  including  altering  upper  airway
anatomy  and  collapsibility,  ventilatory  control  and  increas-
ing  respiratory  work  load.  OSA  itself  contributes  to  the
development  of  obesity.  Moreover,  both  OSA  and  obesity
promote  the  activation  of  inﬂammatory  pathways,  which
is  likely  a  key  mechanism  in  cardiovascular  and  metabolic
disease  processes.4 Anatomical  factors  that  predispose  to
upper  airway  narrowing  should  be  sought  in  the  physical
examination  of  a  patient  suspected  of  having  OSA,  which,
in  addition  to  tonsillar  hypertrophy,  include  retrognathia,
micrognathia,  and  macroglossia.5 However,  the  most  com-
mon  physical  ﬁnding  is  a  non-speciﬁc  narrowing  of  the
pharyngeal  airway  with  reduced  visualization  of  the  poste-
rior  pharyngeal  wall.  The  etiology  of  OSA  in  children  differs
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ommon  cause  of  the  disorder  although  the  increasing  preva-
ence  of  obesity  among  children  in  recent  years  represents
n  important  contributing  factor  in  many  cases.6
OSA  is  a  unique  physiologic  stressor  that  contributes  to
he  development  or  progression  of  many  other  disorders,
articularly  cardiovascular  diseases  and  hypertension.7,8
SA  is  also  associated  with  metabolic,  and  neurocogni-
ive  disease,  increased  cancer-related  deaths,9 and  COPD.10
reatment  with  continuous  positive  airways  pressure  (CPAP)
o  reverse  OSA-related  symptoms  and  multimorbidities  pro-
ides  variable  beneﬁt  in  some  but  not  all  patients.
OSA  is  also  frequent  among  subjects  with  asthma.11,12
n  population  based  studies,  patients  with  asthma  have  a
igniﬁcantly  higher  risk  of  developing  OSA  than  the  general
opulation.13 The  increased  risk  of  OSA  may  be  associated
ith  the  concomitant  presence  of  rhinitis14,15 or  obesity.16
he  potential  contribution  of  nasal  obstruction  to  OSA  has
een  debated.  While  many  reports  have  shown  a  relation-
hip  between  nasal  obstruction  and  OSA,17,18 other  reports
ave  failed  to  ﬁnd  a  relationship.19,20 The  paper  of  Madama
t  al  published  in  this  journal  raises  two  important  issues  in
ultimorbid  asthma  and  OSA11:
.  Asthma  in  old  age  adults:  Asthma  is  common  in  old  age
adults21 and  there  are  overlaps  with  other  diseases  such
as  COPD.  The  overall  management  of  asthma  in  the
elderly  population  is  also  complicated  by  speciﬁc  fea-
tures  that  the  disease  develops  in  the  most  advanced
ages,  and  by  the  difﬁculties  that  the  physician  encoun-
ters  when  approaching  the  older  asthmatic  subjects.22
OSA  increases  in  prevalence  in  old  age  adults  and  those
with  obesity.  The  overlap  between  asthma,  OSA  and
obesity  needs  a  careful  attention23 since  the  treatmentconsidered  in  guidelines.24 AIRWAYS  ICPs  will  approach
this  problem  in  depth  in  order  to  provide  some  recom-
mendations  for  this  new  overlap  syndrome  in  old  age
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adults.11 The  initiative  AIRWAYS  ICPs  (Integrated  care
pathways  for  airway  diseases)25 has  launched  a collab-
oration  to  develop  practical  multisectoral  care  pathways
(ICPs)  to  reduce  the  burden  of  chronic  respiratory  dis-
eases,  their  mortality  and  multimorbidity.  AIRWAYS-ICPs
proposes  a  feasible,  achievable  and  manageable  path-
way  from  science  to  guidelines  and  policies  using  existing
networks  and  stakeholders  committed  to  the  Action  Plan
B3  of  the  European  Innovation  Partnership  on  Active  and
Healthy  Aging  (EIP  on  AHA)26 and  the  WHO  Global  Alliance
against  Chronic  Respiratory  Diseases  (GARD).27,28 It  is
implemented  in  European  countries  and  regions,  as  part
of  the  EIP  on  AHA,  and  is  scaled  up  globally  with  GARD.
The  Renovated  Action  Plan  of  the  EIP  on  AHA  has  a  syn-
ergy  on  chronic  respiratory  diseases  in  old  age  people,
an  under-recognized  societal  problem.
.  Uncontrolled  asthma:  The  risk  of  OSA  is  associated
with  poor  asthma  control.  Patients  with  inhaled  steroid
treatment  have  a  higher  risk  for  OSA  than  those  with-
out  steroid  treatment.13 In  the  SARP-II  (Severe  Asthma
Research  Program),  OSA  risk  is  associated  with  a  neu-
trophilic  airway  inﬂammation  in  asthma,  which  suggests
that  OSA  may  be  an  important  contributor  to  the  neu-
trophilic  asthma.29 Unrecognized  OSA  may  be  a  reason  for
poor  asthma  control,  particularly  among  older  patients.
In  one  study,  CPAP  use  attenuated  the  likelihood  of  severe
asthma  in  older  subjects  by  91%.23 Sleep  disordered
breathing  are  also  increased  in  asthmatic  children  and
the  prevalence  of  sleep  disordered  breathing  increased
with  increasing  asthma  severity.30 Overal,  recent  stud-
ies  indicate  that  OSA  and  asthma  are  closely  associated
in  pathogenesis,  symptoms,  and  therapies,  and  there  is
a  coexistence  of  OSA  in  difﬁcult-to-control  asthmatic
patients.31 Thus,  as  proposed  by  Madama  et  al.,11 in
asthmatic  patients  with  uncontrolled  disease,  symptoms
suggestive  of  OSA  should  be  investigated  (e.g.  daytime
sleepiness,  snoring,  chocking  or  gasping  during  sleep,
recurrent  awakenings)  and  polysomnography  readily  per-
formed  if  needed.  OSA  should  therefore  be  considered
in  patients  with  severe  asthma  either  as  a  differential
diagnosis32 or  as  a  multimorbidity  that  prevents  asthma
control.  Guidelines  should  consider  this  new  overlap  syn-
drome  since  the  treatment  of  OSA  was  shown  to  improve
asthma  control  in  these  patients.
In  patients  with  asthma,  OSA  should  be  investigated
henever  there  is  inadequate  control  of  symptoms  of  noc-
urnal  asthma  despite  the  treatment  recommended  by
uidelines  having  been  administered.  There  is  evidence  in
he  literature  that  the  use  of  CPAP  contributes  to  asthma
ontrol  in  asthma  patients  with  OSA  and  uncontrolled
sthma.24
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